CMCSA
52
6
PG
51
-2
HPE
53
2
SHW
71
-2
GE
85
3
COST
51
-3
SLG
66
4
TGT
50
2
HRB
70
-3
FAST
46
-2
TXT
58
-2
AAL
47
-3
UNP
48
-2
STZ
54
-4
TRIP
60
3
NWL
32
-3
PNR
72
-2
HPQ
62
2
SPG
53
-2
TRV
64
-3
CMCSA
52
6
PG
51
-2
HPE
53
2
SHW
71
-2
GE
85
3
COST
51
-3
SLG
66
4
TGT
50
2
HRB
70
-3
FAST
46
-2
TXT
58
-2
AAL
47
-3
UNP
48
-2
STZ
54
-4
TRIP
60
3
NWL
32
-3
PNR
72
-2
HPQ
62
2
SPG
53
-2
TRV
64
-3
Financhill
Back

Evaxion Biotech AS 10K Form

Sell
28

EVAX
Evaxion Biotech AS

Last Price:
3.05
Seasonality Move:
-19.4%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EVAX News And Ratings

See the #1 stock for the next 7 days that we like better than EVAX

EVAX Financial Statistics

Sales & Book Value

Annual Sales: $73K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.23
Price / Book: 13.88

Profitability

EPS (TTM): -4.50000
Net Income (TTM): $-15.21M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Evaxion Biotech AS Earnings Forecast

Key Evaxion Biotech AS Financial Ratios

  • The Research & Development expenses have been 16,323.29% of Revenue.
  • The Interest Expense is -4.05% of Operating Income.
  • The Net Earning history of EVAX is -30,308.22% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

Evaxion Biotech AS Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EVAX
Website: evaxion-biotech.com

Debt

Debt-to-Equity Ratio: 6.72
Current Ratio: 2.8
Quick Ratio: 2.8

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EVAX Technical Analysis vs Fundamental Analysis

Sell
28
Evaxion Biotech AS (EVAX) is a Sell

Is Evaxion Biotech AS a Buy or a Sell?